Synergistic Combination of Ciplukan (Physalis angulata) Herbs Ethanolic Extract and Doxorubicin on T47D Breast Cancer Cells

Inna Armandari, Kartika Dyah Palupi, Sofa Farida, Adam Hermawan, Ratna Asmah Susidarti, Edy Meiyanto


Doxorubicin is one of chemotherapeutic agent widely used in breast cancer treatment, but in high dose doxorubicin gives negative side effect, including vomit, nausea, immune suppression, and cardiac toxicity. This toxicity hopefully could be reduced by combination chemotherapy using natural herbs such as ciplukan herb. This research was conducted to explore cytotoxic activity of single ciplukan herbs ethanolic extract and its combination with doxorubicin on T47D breast cancer cells. Cytotoxic activity of ciplukan herbs ethanolic extract only and its combination with doxorubicin were tested on T47D cells using MTT assay to obtain IC50 value and combination index (CI), respectively. Single extract showed cytotoxic activity on T47D cells with IC50 value of was 160 µg/ml. Thus, combination treatment from ciplukan herbs ethanolic extract and doxorubicin showed synergistic effect (CI<1,0). This effect was reached at concentration of ciplukan herbs ethanolic extract-doxorubicin 80 μg/ml- 2 nM, 80 μg/ml-4 nM, and 80 μg/ml-8 nM. This research indicated that ciplukan herbs ethanolic extract is potential to be applied as co-chemotherapeutic agent in breast cancer therapy.

Key word : ciplukan herbs, doxorubicin, co-chemotherapy, T47D cells

Full Text:



Chou TC, and Talalay P, 1984, Quantitative analysis of dose effect relationship: The combined effect of multiple drugs or enzyme inhibitors, Adv Enzyme Regul., 22:27-55.

Davis JM, Navolonic PM, Weinstein CR, Steelman LS, Hu, Konovlepa M, Blagosklonny MV, and McCubrey JA, 2003, Raf-1 and Bcl-2 induce distinct and common pathway that contribute to cancer drug resistance, Clin Cancer Res., 9:1161-1170.

Drummond C, 2007, The mechanism of anti-tumour activity of the DNA binding agent SN 28049. Thesis. New Zealand:University of Auckland.

Fitriasari A, Junedi S, Hermawan A, Susidarti RA, and Meiyanto E, 2009, Induction of apoptosis and cell cycle arrest by naringenin to increase the cytotoxic activity of doxorubicin on breast cancer cell lines. The International Conference on Pharmacy and Advance Pharmaceutical Science, 124.

Gosslau A and Rensing L., 2002, Oxidative Stress, Age-dependent cell damage and antioxidative mechanism. Zeitschrift fur Gerontologie und Geriatrie, 35:139-50.

Hsieh WT, Huang KY, Lin HY, and Chung JG., 2006, Physalis angulata induced G2/M phase in human breast cancer cells. Food Chem Toxicol., 4:974-83.

Ismail N., and Alam M., A novel cytotoxic flavonoid glycosides from Physalis angulata. Fitoterapia. 2001;72:676-679.

Leong OK, Sifzizul T, Muhammad T, and Sulaiman SF., 2009, Cytotoxic activities of Physalis minima L. chloroform extract on human lung adenocarcinoma NCI-H23 cell lines by induction of apoptosis. Evid Based Complement Alternat Med., DOI: 10.1093/ecam/nep057.

Magalhaes HI, Veras ML, Torres MR, Alves AP, Pessoa OD, Silveira ER, Costa-Lotufo LV, de Moraes MO, and Pessoa C., 2006, In-vitro and in-vivo antitumour activity of Physalins B and D from Physalis angulata. J Pharm Pharmacol., 58(2):235-241.

Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello, and Alessandro N., 2005, Antitumor effect of curcumin, alone or in combination with cisplatin or doxorubicin on human hepatic cancer cell : Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Canc Lett., 224:53-65.

Reynolds CP and Maurer BJ., 2005, Evaluating response to antineoplastic drug combination in tissues culture models. Method Mol Med., 110:173-83.

Salvensen GS and Riedl SJ., 2008, Caspase mechanism. Adv Exp Med Biol., 615:13-23.

Sharma G., Tyagi AK., Singh RP., Chan DCF., and Agarwal R., 2004, Synergistic Anti-cancer effect of grape seed extract and conventional cytotoxic against human breast cancer carcinoma cells. Breast Cancer Res Treat, 85:1-12.

Shingu K., 1992, Three new Withanolides, Physagulins E, F and G from Physalis angulata L., Chem Pharm Bull., 40:2448-51.

Soares, MBP, Brustolim D, Santos LA, Bellintani MC, Paiva FP, Ribeiro YM, and Tomassini TCB, 2005, Physalins B, F And G, Seco-Steroids purified from Physalis angulata L. inhibit lymphocyte function and allogeneic transplant rejection. Int Immunopharmacol., 6(3):408-14.

Tyagi AK, Agarwal C, Chan, DCF, and Agarwal R., 2004, Synergistic anti-cancer effect of Silibilin with conventional cytotoxic agents Doxorubicin, Cisplatin and Carboplatin against human breast cancer carcinoma MCF-7 and MDA-MB468 cells. Oncol Rep., 1(2):493-99.

Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S, and Bauer JA., 2005, Screening of antioxidant from medicinal plants for cardioprotective effect against Doxorubicin toxicity. Basic Clin Pharmacol Toxic., 96(1):80-87.

Wu SJ, Ng LT, Chen CH, Lin DL, Wang SS, and Lin CC., 2004, Antihepatoma activity of Physalis angulata and Physalis peruviana extracts and their effects on apoptosis in human Hep G2 cells. Life Sci., 74:2061-2073.

Zhao L, Wientjes MG, and Au, JLS., 2004, Evaluation of combination chemotherapy: Integration of nonlinier regression, curve shift, isobologram, and combination index analyses. Clin Canc Res., 10:7994-8004.


Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention

Indexed by:




Indonesian Society for Cancer Chemoprevention